To maintain compliance with our quality and safety standards and to support the continuous improvement of our QMS, 澳门葡京赌场注册制药 has a robust and independent audit program that covers the product lifecycle. 

The audit program is governed by global procedures and covers 澳门葡京赌场注册制药 internal sites and functions as well as suppliers. The scope of each audit depends on the type of operations conducted. The frequency of audits is based on activities performed and applicable risk assessments. The 澳门葡京赌场注册制药 quality audit program normally conducts more than 1 500 audits per year covering internal functions, sites and external suppliers in areas including Good 制造业 Practice (GMP), Good Clinical Practice (GCP), Good Laboratory Practice (GLP) and pharmacovigilance.

An annual audit plan is established to take into account audit frequency and assessed risks. Audits are performed by certified auditors. The subsequent audit report is reviewed and approved independently and distributed to the auditee (internal function, manufacturing site or external supplier) who is responsible for submitting a corrective and preventative action plan which, 在协议, 实现. The audit is closed when all actions in the plan have been completed. 

 

2017

2018

2019

2020

2021

2022

执行的审计总数1

2 252

2 147

1 607

903 

1 419

1 392

内部2

366

250

162

111

125

134

外部3

1 886

1 897

1 445

792

1 294

1 258

引用:

  1. The reduction in the number of audits is primarily due to the divestment of 澳门葡京赌场注册制药 divisions, manufacturing network and supplier consolidation.
  2. Total number of audits that are performed on facilities owned by 澳门葡京赌场注册制药

  3. Total number of audits that are performed on GxP suppliers to 澳门葡京赌场注册制药